Los Angeles

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Eosinophilic oesophagitis2 trials
• Multiple myeloma1 trial

Phase

• Phase 33 trials

Status

• Completed2 trials
• Active, not recruiting1 trial

Lead sponsor

• Celgene3 trials

Running trials

• Active, not recruiting

  Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

  NCT04975997· Phase 3· Celgene· Source

Closed trials

• Completed

  Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis

  NCT04991935· Phase 3· Celgene· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis

  NCT04753697· Phase 3· Celgene· Source